NCT00913848View on ClinicalTrials.gov

To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
EpilepsyBipolar Disorder
Interventions
DRUG

Divalproex Sodium 500 mg DR Tablets (Sandoz Inc., USA)

DRUG

Depakote 500 mg DR Tablets (Abbott Laboratories, USA)

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY

NCT00913848 - To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fed Conditions | Biotech Hunter | Biotech Hunter